Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06276400 · ClinicalTrials.gov registry record · NA

LPFC Organization in Emotion-Duration Difference Estimation

A NA study of Healthy, sponsored by University of California, Santa Barbara.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06276400: Recruiting NA study of Healthy, sponsored by University of California, Santa Barbara.

NCT06276400 is a NA study of Healthy that is actively recruiting participants, run by University of California, Santa Barbara. The registered enrollment target is 50 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06276400, a NA study of Healthy, is actively recruiting participants, sponsored by University of California, Santa Barbara.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

To support optimal behavior in daily life, goals and responses following emotional events should ideally incorporate not only the valence and intensity of prior emotional episodes but also their temporal features, such as the relative duration of positive vs. negative attributes. However, how specific brain regions contribute to the integration of temporal and emotional information and promote goal-directed response remains unknown. The goal of this study is to examine how specific brain regions track both emotional and temporal information of dynamic emotional events to inform other related brain regions to guide goal-oriented and context-appropriate actions. The investigators will scan healthy human participants using functional MRI (fMRI) while they view emotional image sequences and track the associated emotional and temporal (duration) information, and act accordingly. The investigators will employ multivariate patterns analysis and pattern similarity analysis to identify brain regions that represent (can decode) emotion, time, and their combined signals, as well as brain regions that represent the associated action goal. In addition, to infer the causal contributions of these brain regions in forming task-relevant representations (emotion, time, and action goal), the same participants will be recruited to receive transcranial magnetic stimulation (TMS) in these regions.

Primary Outcome

The investigators will use BOLD activation patterns measured from each ROI to fit quantitative models of emotional valence, time, and action goal encoding. These models will be used to classify stimulus representations on experimental trials to quantify how stimulus representations are encoded in each brain region studies, and how these representations change across experimental manipulations. These measurements will be used to test the impact of stimulus manipulations on stimulus representation

Conditions Studied

Interventions

  • OTHER Emotion valence
  • OTHER Time
  • DEVICE TMS Stimulation

Study Locations (1)

California

  • University of California, Santa Barbara - Santa Barbara

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-01-29
Est. Completion 2028-03-31
Phase NA

What NCT06276400 shows while recruiting

NCT06276400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Emotion valence is the first listed.

NCT06276400 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06276400 about?

NCT06276400 is a clinical study titled "LPFC Organization in Emotion-Duration Difference Estimation". To support optimal behavior in daily life, goals and responses following emotional events should ideally incorporate not only the valence and intensity of prior emotional episodes but also their temporal features, such as the relative duration of positive vs. negative attributes. However, how specif...

What is the current status of trial NCT06276400?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-01-29. Estimated completion is 2028-03-31.

What conditions does trial NCT06276400 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06276400?

The interventions under investigation include: Emotion valence (OTHER), Time (OTHER), TMS Stimulation (DEVICE).

Who is sponsoring clinical trial NCT06276400?

This trial is sponsored by University of California, Santa Barbara, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06276400 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06276400's enrollment target sits among peer trials

50 448th of 1090 higher than 618 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

  • NCT01746836 · 50 participants · Phase 2

    Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06276400, the US trial registry maintained by the National Library of Medicine. NCT06276400 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.